美股新聞 標題聯播 · 近 24 小時 336 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · SEPN近 30 天 2 則 · 第 1 / 1 頁
- Septerna (SEPN) Heads To Healthcare Conferences, Is The Valuation Already Too Rich?
- Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
- Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates
- Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
- Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates
- Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?
- Septerna to Present Preclinical Characterization of SEP-479, an Oral PTH1R Agonist for Hypoparathyroidism, at 2026 ENDO Annual Meeting
- Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
- Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings Forecasts
- Earnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported And Analysts Are Boosting Their Estimates
- Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates
- Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
- How Analyst Upgrade and Conference Spotlight Will Impact Septerna (SEPN) Investors
- Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。